Home » Reports » AstraZeneca plc 6.9% Potential Upside Indicated by Bryan Garnier

AstraZeneca plc 6.9% Potential Upside Indicated by Bryan Garnier

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Upgrades’ with the recommendation being set at ‘BUY’ today by analysts at Bryan Garnier. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Bryan Garnier have set a target price of 7950 GBX on its stock. This would imply the analyst believes there is now a potential upside of 6.9% from today’s opening price of 7439 GBX. Over the last 30 and 90 trading days the company share price has increased 1 points and increased 184 points respectively. The 1 year high share price is 7646 GBX while the year low stock price is currently 5312 GBX.

AstraZeneca plc has a 50 day moving average of 7,271.53 GBX and the 200 Day Moving Average price is recorded at 6,682.96. There are currently 1,311,904,600 shares in issue with the average daily volume traded being 1,893,106. Market capitalisation for LON:AZN is £98,051,749,804 GBP.

Join us on our new LinkedIn page

Follow us on LinkedIn